semaglutide and ed 💉 The FDA has approved (Ozempic) to reduce the risk of worsening kidney disease, kidney failure, cardiovascular death in adults with type 2 diabetes (T2D) and chronic kidney disease (CKD) This post isn't about fear.

This does not diminish the therapeutic value of GLP-1 medications but instead underscores the importance of viewing weight loss through a broader physiological lens that accounts for body composition and long-term cardiometabolic health

Open safety certificate Features 01 Weight management 02 Improved blood sugar control 03 Cardiovascular support 04 Higher energy expenditure 05 Better liver health 06 Potential healthy aging benefits FAQ What is Retatrutide and how is it different from other GLP peptides

in human research, oral precursors raise blood NAD+ reliably, while injectable NAD+ pharmacokinetics are less fully characterized

The approval could help spur a turnaround for Novo after a rocky year of sliding shares, profit warnings and slowing sales of its injectable Wegovy amid intense competition from Lilly and pressure from compounded versions

Bone and musculoskeletal research: Some work has extended into bone repair and osteoporosis models, where AOD9604 has shown early signs of supporting bone remodeling, though this area is less developed than its fat metabolism and cartilage research

Pharmacy Compounding Advisory Committee meeting, 23 to 24 July 2026